$AMGN AMGEN INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in AMGEN INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in AMGEN INC. Insider overview, share value development, latest insider transactions and email notifications about new events in AMGEN INC for free.

CIK Number: 0000318154
IRS Number: 953540776
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: AMGN
Company Address: ONE AMGEN CENTER DRIVE THOUSAND OAKS 91320
Phone number: (805) 447-1000
Former name: AMGEN, date of change: 1987-03-05

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. Its products include aranesp, blincyto, corlanor, enbrel, epogen, imlygic, kyprolis, neulasta, neupogen, nplate, parsab, prolia, repatha, sensipar, vectibix, and xgeva. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Market Capitalization: $124.07B
Prev close: $166.82
Average Daily Volume: 3,895,330
Days Low: $166.32
Year Low: $133.64
Year High: $176.85

AMGEN INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
de Carbonnel FrancoisDirector15,5282,590,381shares bought: 7,509 / shares sold: -7,254 BUYNov 08 20171 month ago
Harper Sean EEVP, Research & Development56,1069,359,603shares bought: 32,120 / shares sold: -66,259 STRONG SELLDec 12 20175 days ago

View all AMGEN INC insiders.

AMGEN INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 12 2017AMGNAMGEN INCHarper Sean EEVP, Research & Dev ...SellS176.831,525269,66656,10657.6 K to 56.1 K (-2.65 %)
Nov 14 2017AMGNAMGEN INCHarper Sean EEVP, Research & Dev ...SellS171.581,525261,66057,63159.2 K to 57.6 K (-2.58 %)
Nov 08 2017AMGNAMGEN INCde Carbonnel FrancoisDirectorSellS173.614,000694,42215,52819.5 K to 15.5 K (-20.48 %)
Oct 10 2017AMGNAMGEN INCHarper Sean EEVP, Research & Dev ...SellS185.951,525283,57459,15660.7 K to 59.2 K (-2.51 %)
Aug 04 2017AMGNAMGEN INCGraham Jonathan PSVP, Gen. Counsel & ...Payment of ExerciseF174.186,7471,175,19244,16550.9 K to 44.2 K (-13.25 %)
Aug 02 2017AMGNAMGEN INCSantos EstebanEVP, OperationsPayment of ExerciseF174.13639111,26931,47832.1 K to 31.5 K (-1.99 %)
Aug 01 2017AMGNAMGEN INCMeline David WEVP & CFOPayment of ExerciseF174.517,5621,319,64547,92055.5 K to 47.9 K (-13.63 %)
Jun 02 2017AMGNAMGEN INCBALTIMORE DAVIDDirectorSellS153.933,700569,54131,15934.9 K to 31.2 K (-10.61 %)
May 24 2017AMGNAMGEN INCPatton Cynthia MSVP & CCOSellS154.402,922451,16421,29224.2 K to 21.3 K (-12.07 %)
May 24 2017AMGNAMGEN INCPatton Cynthia MSVP & CCOGiftG0.00346024,21424.6 K to 24.2 K (-1.41 %)
May 03 2017AMGNAMGEN INCSantos EstebanEVP, OperationsOption ExerciseA162.6030,5014,959,46330,501
May 03 2017AMGNAMGEN INCSantos EstebanEVP, OperationsGrantA0.003,444034,14430.7 K to 34.1 K (+11.22 %)
May 03 2017AMGNAMGEN INCPiacquad DavidSVP, Business Devel ...Option ExerciseA162.608,7141,416,8968,714
May 03 2017AMGNAMGEN INCPiacquad DavidSVP, Business Devel ...GrantA0.00984033,53332.5 K to 33.5 K (+3.02 %)
May 03 2017AMGNAMGEN INCPatton Cynthia MSVP & CCOOption ExerciseA162.608,7141,416,8968,714

View all AMGEN INC insider transactions.